Catalyst Wire Dossier Catalyst Wire Dossier

Trip HF Study - Triple Resynchronization in Paced Heart Failure Patients

· Abbott Medical Devices
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trip HF Study - Triple Resynchronization in Paced Heart Failure Patients, covering 2019-02-04 to 2019-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients [NA]

See pricing